Nontraditional cardiovascular risk factors

被引:52
作者
Oparil, S
Oberman, A
机构
[1] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA
关键词
cardiovascular risk factor; C-reactive protein; homocysteine; lipoprotein Lp (a); stress; insulin; angiotensin; oxidative stress;
D O I
10.1097/00000441-199903000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A number of newer, "nontraditional" cardiovascular risk factors have been identified based on recent studies of the pathogenesis of atherosclerosis and atherothrombotic cardiovascular events, These include chronic inflammation and its markers, such as C-reactive protein; homocysteine; oxidative stress or endothelial dysfunction; lipoprotein Lp (a); psychosocial factors, such as environmental stress and responsiveness to stress; plasma insulin levels and markers of insulin resistance; and activation of the renin-angiotensin system, which is in part a function of polymorphisms in genes for components of the system, such as angiotensinogen and the angiotensin II type 1 receptor, The strength of the associations of the newer risk factors with cardiovascular therapy are currently being tested. This review will briefly discuss evidence that these risk factors are related to cardiovascular disease.
引用
收藏
页码:193 / 207
页数:15
相关论文
共 111 条
[21]   Chronic infections and coronary heart disease: is there a link? [J].
Danesh, J ;
Collins, R ;
Peto, R .
LANCET, 1997, 350 (9075) :430-436
[22]   RAISED C-REACTIVE PROTEIN-LEVELS IN SERUM FROM SMOKERS [J].
DAS, I .
CLINICA CHIMICA ACTA, 1985, 153 (01) :9-13
[23]  
DEBEER FC, 1982, BRIT HEART J, V47, P239
[24]   Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction [J].
Denollet, J ;
Brutsaert, DL .
CIRCULATION, 1998, 97 (02) :167-173
[25]   ELEVATED SERUM LIPOPROTEIN(A) IS A RISK FACTOR FOR CLINICAL RECURRENCE AFTER CORONARY BALLOON ANGIOPLASTY [J].
DESMARAIS, RL ;
SAREMBOCK, IJ ;
AYERS, CR ;
VERNON, SM ;
POWERS, ER ;
GIMPLE, LW .
CIRCULATION, 1995, 91 (05) :1403-1409
[26]   A PERSPECTIVE ON TYPE-A BEHAVIOR AND CORONARY-DISEASE [J].
DIMSDALE, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (02) :110-112
[27]   The role of infection in restenosis and atherosclerosis: Focus on cytomegalovirus [J].
Epstein, SE ;
Speir, E ;
Zhou, YF ;
Guetta, E ;
Leon, M ;
Finkel, T .
LANCET, 1996, 348 :S13-S17
[28]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[29]   The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension [J].
Estacio, RO ;
Jeffers, BW ;
Hiatt, WR ;
Biggerstaff, SL ;
Gifford, N ;
Schrier, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :645-652
[30]   CARDIOVASCULAR CHARACTERISTICS IN ADOLESCENTS WHO DEVELOP ESSENTIAL-HYPERTENSION [J].
FALKNER, B ;
KUSHNER, H ;
ONESTI, G ;
ANGELAKOS, ET .
HYPERTENSION, 1981, 3 (05) :521-527